Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ... Science 348 (6230), 124-128, 2015 | 8063 | 2015 |
Genetic basis for clinical response to CTLA-4 blockade in melanoma A Snyder, V Makarov, T Merghoub, J Yuan, JM Zaretsky, A Desrichard, ... New England Journal of Medicine 371 (23), 2189-2199, 2014 | 4466 | 2014 |
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET H Peinado, M Alečković, S Lavotshkin, I Matei, B Costa-Silva, ... Nature medicine 18 (6), 883-891, 2012 | 3871 | 2012 |
Immunologic correlates of the abscopal effect in a patient with melanoma MA Postow, MK Callahan, CA Barker, Y Yamada, J Yuan, S Kitano, Z Mu, ... New England Journal of Medicine 366 (10), 925-931, 2012 | 2152 | 2012 |
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 CC Chang, R Ciubotariu, JS Manavalan, J Yuan, AI Colovai, F Piazza, ... Nature immunology 3 (3), 237-243, 2002 | 1066 | 2002 |
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido VP Balachandran, MJ Cavnar, S Zeng, ZM Bamboat, LM Ocuin, H Obaid, ... Nature medicine 17 (9), 1094-1100, 2011 | 598 | 2011 |
Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab A Martens, K Wistuba-Hamprecht, MG Foppen, J Yuan, MA Postow, ... Clinical Cancer Research 22 (12), 2908-2918, 2016 | 561 | 2016 |
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial BC Carthon, JD Wolchok, J Yuan, A Kamat, DS Ng Tang, J Sun, G Ku, ... Clinical Cancer Research 16 (10), 2861-2871, 2010 | 534 | 2010 |
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival GY Ku, J Yuan, DB Page, SEA Schroeder, KS Panageas, RD Carvajal, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 492 | 2010 |
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit J Yuan, S Gnjatic, H Li, S Powel, HF Gallardo, E Ritter, GY Ku, ... Proceedings of the National Academy of Sciences 105 (51), 20410-20415, 2008 | 406 | 2008 |
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab J Yuan, M Adamow, BA Ginsberg, TS Rasalan, E Ritter, HF Gallardo, Y Xu, ... Proceedings of the National Academy of Sciences 108 (40), 16723-16728, 2011 | 397 | 2011 |
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy W Ma, BM Gilligan, J Yuan, T Li Journal of hematology & oncology 9, 1-21, 2016 | 367 | 2016 |
Indoleamine 2, 3-dioxygenase–expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells DJ Chung, M Rossi, E Romano, J Ghith, J Yuan, DH Munn, JW Young Blood, The Journal of the American Society of Hematology 114 (3), 555-563, 2009 | 306 | 2009 |
Novel technologies and emerging biomarkers for personalized cancer immunotherapy J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ... Journal for immunotherapy of cancer 4, 1-25, 2016 | 265 | 2016 |
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) S Janetzki, KS Panageas, L Ben-Porat, J Boyer, CM Britten, TM Clay, ... Cancer Immunology, Immunotherapy 57, 303-315, 2008 | 223 | 2008 |
Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either … G Ratzinger, J Baggers, MA de Cos, J Yuan, T Dao, JL Reagan, C Munz, ... The Journal of Immunology 173 (4), 2780-2791, 2004 | 214 | 2004 |
Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma MA Postow, M Manuel, P Wong, J Yuan, Z Dong, C Liu, S Perez, ... Journal for immunotherapy of cancer 3, 1-5, 2015 | 212 | 2015 |
Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy D Ng Tang, Y Shen, J Sun, S Wen, JD Wolchok, J Yuan, JP Allison, ... Cancer immunology research 1 (4), 229-234, 2013 | 212 | 2013 |
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation MA Perales, JD Goldberg, J Yuan, G Koehne, L Lechner, ... Blood, The Journal of the American Society of Hematology 120 (24), 4882-4891, 2012 | 197 | 2012 |
A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling HL McArthur, A Diab, DB Page, J Yuan, SB Solomon, V Sacchini, ... Clinical Cancer Research 22 (23), 5729-5737, 2016 | 195 | 2016 |